IL196773A0 - Stable solid elsamitrucin salts suitable for pharmaceutical formulations - Google Patents
Stable solid elsamitrucin salts suitable for pharmaceutical formulationsInfo
- Publication number
- IL196773A0 IL196773A0 IL196773A IL19677309A IL196773A0 IL 196773 A0 IL196773 A0 IL 196773A0 IL 196773 A IL196773 A IL 196773A IL 19677309 A IL19677309 A IL 19677309A IL 196773 A0 IL196773 A0 IL 196773A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulations
- stable solid
- salts suitable
- elsamitrucin salts
- solid elsamitrucin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/069693 WO2008143677A1 (en) | 2007-05-24 | 2007-05-24 | Stable solid elsamitrucin salts suitable for pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
IL196773A0 true IL196773A0 (en) | 2009-11-18 |
Family
ID=39639324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL196773A IL196773A0 (en) | 2007-05-24 | 2009-01-28 | Stable solid elsamitrucin salts suitable for pharmaceutical formulations |
Country Status (6)
Country | Link |
---|---|
KR (1) | KR20100014080A (en) |
CN (1) | CN101472938A (en) |
CA (1) | CA2654877A1 (en) |
IL (1) | IL196773A0 (en) |
MX (1) | MX2008015971A (en) |
WO (1) | WO2008143677A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2222276A1 (en) * | 2007-12-19 | 2010-09-01 | Spectrum Pharmaceuticals, Inc. | Stable elsamitrucin salt formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518589A (en) * | 1983-10-03 | 1985-05-21 | Bristol-Myers Company | BBM-2478 Antibiotic complex |
HU210499B (en) * | 1991-05-30 | 1995-04-28 | Bristol Myers Squibb Co | Process for preparing 6-o-alkylelsamicin a deriv.s and pharmaceutical compn.s contg. them |
US5508268A (en) * | 1993-08-12 | 1996-04-16 | Bristol-Myers Squibb | Parenteral elsamitrucin formulations |
-
2007
- 2007-05-24 WO PCT/US2007/069693 patent/WO2008143677A1/en active Application Filing
- 2007-05-24 CA CA002654877A patent/CA2654877A1/en not_active Abandoned
- 2007-05-24 CN CNA2007800223402A patent/CN101472938A/en active Pending
- 2007-05-24 KR KR1020087030847A patent/KR20100014080A/en not_active Application Discontinuation
- 2007-05-24 MX MX2008015971A patent/MX2008015971A/en not_active Application Discontinuation
-
2009
- 2009-01-28 IL IL196773A patent/IL196773A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20100014080A (en) | 2010-02-10 |
WO2008143677A1 (en) | 2008-11-27 |
MX2008015971A (en) | 2009-01-12 |
CA2654877A1 (en) | 2008-11-27 |
CN101472938A (en) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1217440A1 (en) | Acid containing lipid formulations | |
ZA200908019B (en) | Controlled release pharmaceutical compositions for prolonged effect | |
GB0709031D0 (en) | Pharmaceutical compounds | |
IL201366A0 (en) | Pharmaceutical compounds | |
GB0721095D0 (en) | Pharmaceutical compounds | |
GB0711656D0 (en) | Formulations | |
EP2178893A4 (en) | Oral formulations for picoplatin | |
EP2001500A4 (en) | Formulations for ecallantide | |
GB0707087D0 (en) | Pharmaceutical compounds | |
GB0725214D0 (en) | Pharmaceutical compounds | |
GB0711957D0 (en) | Formulations | |
GB0704932D0 (en) | Pharmaceutical compounds | |
GB0721669D0 (en) | Pharmaceutical compounds | |
GB0710899D0 (en) | Formulations | |
ZA201007197B (en) | Raloxifene pharmaceutical formulations | |
IL198160A0 (en) | Pharmaceutical formulations | |
IL196773A0 (en) | Stable solid elsamitrucin salts suitable for pharmaceutical formulations | |
GB0705179D0 (en) | Formulations | |
ZA200901424B (en) | Stable solid elsamitrucin salts suitable for pharmaceutical formulations | |
GB0713093D0 (en) | Pharmaceutical formulations | |
IL206473A0 (en) | Stable elsamitrucin salt formulations | |
GB0810217D0 (en) | Pharmaceutical formulations | |
GB0813031D0 (en) | Pharmaceutical formulations | |
GB0615461D0 (en) | Pharmaceutical formulations | |
GB0709150D0 (en) | Pharmaceutical compounds |